Objectives: Venous to arterial Co 2 difference correlates with cardiac output in critically ill adults, but its utility in pediatric patients is unclear. We sought to correlate venous to arterial Co 2 difference with other cardiac output surrogates (arteriovenous oxygen saturation difference, central venous oxygen saturation, and lactate) and investigate its capacity to predict poor outcomes associated with low cardiac output (low cardiac output syndrome) in infants after cardiac surgery with cardiopulmonary bypass. Design: Retrospective chart review. Poor outcome was defined as any inotrope score greater than 15; death, cardiac arrest, extracorporeal membrane oxygenation; and unplanned surgical reintervention. Setting: Pediatric cardiovascular ICU. Patients: One hundred thirty-nine infants less than 90 days who underwent cardiopulmonary bypass, from October 2012 to May 2015. Intervention: None. Measurements and Main Results: Two hundred ninety-six arterial and venous blood gas pairs from admission (n = 139), 6 (n = 62), 12 (n = 73), and 24 hours (n = 22) were included in analysis. For all pairs, venous to arterial Co 2 difference was moderately correlated with arteriovenous oxygen saturation difference (R 2 = 0.53; p < 0.01) and central venous oxygen saturation (R 2 = -0.43; p < 0.01), but not lactate. At admission, venous to arterial Co 2 difference was also moderately correlated with central venous oxygen saturation (R 2 = -0.40; p < 0.01) and arteriovenous oxygen saturation difference (R 2 = 0.55; p < 0.01), but not lactate. Thirty-four of 139 neonates (24.5%) had poor outcome. Median admission venous to arterial Co 2 difference was 5.9 mm Hg (3.8-9.2 mm Hg). Patients with poor outcome had median admission venous to arterial Co 2 difference 8.3 (5.6-14.9) versus 5.4 mm Hg (3.0-8.4 mm Hg) in those without poor outcome. Venous to arterial Co 2 difference (area under the curve = 0.69; p < 0.01), serum lactate (area under the curve = 0.64; p = 0.02), and central venous oxygen saturation (area under the curve = 0.74; p < 0.01) were predictive of poor outcome. After controlling for covariates, admission venous to arterial Co 2 difference remained significantly associated with poor outcome (odds ratio, 1.3; 95% CI, 1.1-1.45), including independent association with mortality (odds ratio, 1.2; 95% CI, 1.07-1.31). Conclusions: Venous to arterial Co 2 difference is correlated with important surrogates of cardiac output, and is associated with poor outcome and mortality related to low cardiac output syndrome after cardiac surgery in infants. Prospective validation of these findings, including confirmation that venous to arterial Co 2 difference can identify low cardiac output syndrome in real time, is warranted. (Pediatr Crit Care Med 2017; 18:228-233) Key Words: cardiopulmonary bypass; congenital heart disease; infant; postoperative care; venoarterial Co 2 difference V enous to arterial Co 2 partial pressure difference (AVco 2 ) measures the circulatory clearance of tissue Co 2 and is correlated with cardiac output (CO) in critically ill adult patients (1) (2) (3) (4) (5) . Widening of AVco 2 represents an imbalance between CO and tissue Co 2 production. AVco 2 monitoring is gaining momentum as a surrogate of CO in critically ill adults; an increased AVco 2 gradient is associated with decreased CO and morbidity in adult patients with shock from hemorrhage sepsis and cardiac surgery (1) (2) (3) (4) (5) (6) (7) (8) (9) .
Low cardiac output syndrome (LCOS) occurs frequently after cardiac surgery in infants and is a major contributor to postoperative morbidity. However, there is no consensus for the diagnostic criteria of LCOS and accurate detection of early CO insufficiency may be difficult. Clinicians use metrics such as serum lactate, central venous oxygen saturations (Scvo 2 ), regional near-infrared spectroscopy (NIRS), and inotrope requirements as bedside surrogates of CO, but these may be influenced by multiple patient and management factors unrelated to LCOS. Therefore, these variables may have inconsistent discrimination for diagnosis of LCOS and related outcomes. Little is known about the utility of AVco 2 monitoring in the pediatric cardiovascular ICU. One previous study correlated AVco 2 with Scvo 2 after pediatric biventricular cardiac surgery but did not evaluate outcomes (10) .
In this study, we sought to determine if AVco 2 is associated with LCOS after cardiac surgery in infants via correlation with traditional bedside surrogates of CO including serum lactate, Scvo 2 , and arteriovenous oxygen saturation difference (AVo 2 ). As a secondary aim, we sought to identify the association between increased AVco 2 and postoperative morbidity and mortality.
MATERIALS AND METHODS

Patients and Data Collection
The study was approved and written informed consent was waived by the institutional review board of the University of Alabama at Birmingham. This is a retrospective chart review of all patients less than or equal to 90 days old admitted to the pediatric cardiovascular ICU at Children's of Alabama from October 2012 to May 2015 who underwent cardiac surgery for congenital heart disease with cardiopulmonary bypass (CPB). Patients were excluded if they did not have paired arterial and venous gases at admission (n = 35) or if they required extracorporeal membrane oxygenation (ECMO) before leaving the operating room (n = 5).
Demographic data collected included weight, age at surgery, Society of Thoracic Surgeons-European Association for Cardiothoracic Surgery Congenital Heart Surgery Mortality Categories (STAT), and open chest and single ventricle status. We also collected hospital length of stay (HLOS), length of mechanical ventilation (MV) (time in hours until the first successful extubation of at least 48 hr), admission, 12-and 24-hour inotrope score (IS), serum creatinine level up to seven days postsurgical intervention, need for postsurgical ECMO, cardiac arrest, and mortality. Modified IS was calculated as previously reported (11); milrinone was not included in calculation because of ubiquitous use at our institution.
Blood Gas Data
All paired arterial and venous blood gases in the first 24 hours from admission were collected. Arterial and venous blood gases were "paired" if they were timed within 30 minutes of each other. Measured oxygen saturation, Co 2 , and arterial lactate were extracted. The following pairs were included in the analysis: admission, 6, 12, and 24 hours. Pairs were assigned to a group if within ± 2 hours of time category. Any gases obtained outside these times were not considered in analysis. AVo 2 was calculated as the difference between the measured arterial minus the measured venous cooximetry. AVco 2 was calculated as the difference between the venous and arterial Co 2 .
In order to remove pairs contaminated by right to left shunting due to atrial level communication (e.g., single ventricle and/or residual lesions in patients with a line in or near the right atrium), blood gases were excluded from analysis if they met the following criteria: tip of central line in the right atrium at admission chest x-ray and AVo 2 less than 10% and AVco 2 difference less than 2 mm Hg. All blood gas analyses were performed on Radiometer ABL 90-FLEX (Radiometer America ABL90, Brea, CA).
Definitions "Poor outcome" was defined a priori as a composite of morbidities related to LCOS. The morbidities included were IS greater than 15, death, cardiac arrest, and ECMO within 48 hours of admission, and any unplanned surgical reinterventions during hospital stay. Only gas pairs obtained prior ECMO, cardiopulmonary resuscitation, and surgical reintervention were included. Secondary outcomes analyzed were prolonged HLOS and prolonged MV (> 75% of study population for both) and acute kidney injury (AKI) defined as doubling of baseline serum creatinine within 7 days after surgery. Scvo 2 samples were taken from central venous catheters.
Statistical Analysis
Continuous variables not normally distributed were summarized as a median with interquartile range (IQR), with group comparison performed using the Mann-Whitney test. Continuous variables with a normal distribution were summarized as means with sds and compared using the unpaired Student t test. Categorical data were compared using chi-square or Fisher exact test as indicated. Paired samples Student t test was used to compare variables across time categories. Bivariate correlations were analyzed using Pearson for parametric variables and Spearman for nonparametric variables. Receiver operating curves (ROCs) were used to find a discrimination threshold. Multiple logistic regression was used to explore the relationship of all oxygen delivery variables (lactate, AVo 2 , Scvo 2 , and AVco 2 ) with death and/or poor outcome. All variables with a p value of less than 0.1 were included in the model. Backward stepwise method with likelihood ratio was used. Variables with a Wald statistic greater than 0.1 were removed from the model. Odds ratio (OR) with 95% CIs are reported. All p values of less than 0.05 were considered statistically significant. All statistical tests were two-tailed. SPSS version 23 (IBM, Chicago, IL) was used for all statistical analysis.
RESULTS
Patients
One hundred seventy-nine surgeries were performed on infants less than 90 days old during the study period. One hundred thirty-nine patients met inclusion and exclusion criteria for analysis. Patient characteristics and their association with poor outcome and mortality are presented in outcome and mortality were also associated with longer duration of MV and higher prevalence of AKI. Poor outcome but not mortality was associated with longer HLOS (Table 1) . Figure 1 shows the medians and IQR of AVco 2 , AVo 2 , Scvo 2 , and lactate at all four time points in the first 24-postoperative hours. Median admission AVco 2 was 5.9 mm Hg (3.8-9.2 mm Hg). AVco 2 and AVo 2 significantly increase compared with admission levels over the first 24-hour postadmission, whereas Scvo 2 and lactate decrease. A total of 296 arterial and venous gas pairs were identified for analysis: 139 at admission, 62 at 6 hours, 73 at 12 hours, and 22 at 24 hours. Including all 296 pairs, AVco 2 was moderately correlated with AVo 2 (R 2 = 0.53; p < 0.01) and Scvo 2 (R 2 = -0.43; p < 0.01) but not correlated with lactate (R 2 = 0.05; p = 0.42). Table 2 shows correlation between AVco 2 and other makers of oxygen delivery at different time points. On admission, AVco 2 showed a moderate correlation with AVo 2 but weaker correlation at 6, 12, and 24 hours. AVco 2 had a negative moderate correlation with Scvo 2 at all time points. These correlations persisted in subanalysis of single ventricle patients (Table 2) . Lactate on the other hand had weak correlation with AVco 2 only at 6 hours and did not significantly correlate with Scvo 2 or AVo 2 at any time points (data not shown).
AVco 2 Trends and Correlation With Other CO Surrogate Variables
AVco 2 and Poor Outcome
Thirty-four of 139 infants (24.5%) had poor outcome (mortality, n = 14; ECMO, n = 8; CPR, n = 19; unplanned surgical intervention, n = 12; admission IS > 15, n = 7). Note, some patients had more than one outcome. Admission AVco 2 , Scvo 2 , and lactate levels were significantly associated with poor outcome but not AVo 2 ( Table 3) AVco 2 represents the adequacy of venous blood flow (or CO) to clear the Co 2 generated by the peripheral tissues (12) . Contrary to oxygen derived variables such as Scvo 2 and AVo 2 , AVco 2 is not impacted by pulmonary venous desaturation, intracardiac shunting, anemia, insufficient inspired oxygen, etc that may decrease oxygen delivery independent of CO (13, 14) . AVco 2 will not deviate if there is normal CO, as the venous and pulmonary blood flow will be sufficient to clear the excess Co 2 produced by hypoxic tissues (12) . Therefore, it follows that AVco 2 may have stronger correlation with impaired cardiac index compared with oxygen derived variables. Combining Scvo 2 with AVco 2 monitoring may enable the clinician to more accurately target the management of LCOS and/or tissue hypoxia in this high-risk population. This study provides the first "normal values" of AVco 2 for a heterogeneous group of infants after CPB at four time points: cardiovascular ICU admission, 6, 12, and 24 hours (Fig. 1) . We did not identify a cutoff for "elevated" AVco 2 a priori for this study-as this value has yet to be determined in this cohort of infants less than 90 days old after cardiac surgery with CPB (10). The median admission AVco 2 in our cohort was 5.9 mm Hg. It rises over next several hours-peaking at 12-24 hours with a median of 10.5 mm Hg. It is unclear why the AVco 2 continues to increase after admission; this time course may mirror the presence of LCOS that often follows CPB and cardiac surgery in infants. Prospective validation of our "normal" AVco 2 values across a strata of surgical procedures and patient characteristics is necessary before they can be used as reference values. It is likely that there is a difference in normalAVco 2 values among high-and low-risk cohorts as well as single ventricle versus two ventricle physiologies.
Postoperative LCOS is a well described clinical condition after cardiac surgery in neonates and infants and is likely a major contributor to morbidity and mortality. However, there is a lack of consensus on diagnostic criteria for LCOS. Clinicians often use deviations in serum lactate, Scvo 2 , AVo 2 , and NIRS as surrogates of LCOS at the bedside. They have shown to have significant, yet imperfect and variable levels of correlations with LCOS (15) (16) (17) (18) (19) (20) . We offer AVco 2 as another potential bedside metric to be considered for inclusion into scoring systems or diagnostic criteria to improve current definitions of LCOS. Not only does AVco 2 have moderate correlation with other CO surrogates (Scvo 2 and AVo 2 ), but the additional association of elevated AVco 2 in patients with persistent inotropic support as well as its association with morbidity and mortality related to low CO gives indirect evidence that elevated AVco 2 may reflect real time LCOS.
Several adult studies have demonstrated that AVco 2 is correlated with simultaneous measures of cardiac index (1) (2) (3) (4) (5) . Additionally, studies in critically ill adults after abdominal surgery or with septic shock demonstrated that patients with an increased AVco 2 gradient were more likely to have increased postoperative complications and poor outcomes, including death-even in patients who had a normal Scvo 2 (> 70%) (6, 9, 21, 22) . In our cohort, increased AVco 2 was associated with poor outcome even after controlling for STAT category and other covariates. Of the four variables evaluated (admission Scvo 2 , AVo 2 , lactate, and AVco 2 ), only admission AVco 2 remained significantly associated with death after adjusting for STAT category. Potential to identify a cohort of patients at high risk for LCOS and related morbidity immediately upon postoperative admission to the cardiovascular ICU, independent of their surgical risk category, makes AVco 2 a particularly promising monitoring tool. Unfortunately, due to the flatness of our ROC, we were unable to identify a well performing cutoff AVco 2 value that was associated with poor outcome in this cohort. Combining AVco 2 (a physiologic estimate of LCOS) with a validated therapy-based LCOS surrogate (i.e., IS) at cardiovascular ICU admission could be a next step for prospective research in this area-with the aim to create a score for accurate and early diagnosis of real time LCOS as well as the ability to precisely predict morbidity directly related to LCOS (11). Beyond those already discussed, our study has limitations including those inherent with any retrospective study. The study population was a cohort of infants less than 90 days old, and our findings may not be generalizable to other populations with cardiac disease or similar cohorts at different institutions. Although AVco 2 correlates with some surrogates of LCOS, we do not compare AVco 2 to concurrent echocardiograms or invasive hemodynamic cardiac index monitoring to determine the true capacity of AVco 2 to directly measure/identify LCOS. Additionally, due to its retrospective nature and limitations of hourly electronic charting, we could not precisely compare AVco 2 to simultaneous hemodynamic variables, NIRS, IS, or preload augmentation to support presence of LCOS. Prospective evaluation of AVco 2 with real time clinical markers and therapeutic interventions consistent with LCOS is necessary to validate the discriminative ability of AVco 2 to identify LCOS. To investigate the association of AVco 2 with postoperative morbidity, we chose a composite poor outcome given the relative low frequency of each complication. Although we demonstrated AVco 2 association with important outcomes that are certainly associated with presence of LCOS, we concede some items of our composite poor outcomes could occur without LCOS. Our retrospective study was subject to the selection bias of drawing more laboratory samples in patients who had higher severity of illness. Utilization of only the admission blood gas pairs for the outcomes part of this analysis minimized this bias as all patients were subject to protocolized laboratory draw at this time point. Removing atrial line blood gases from our analysis limits the ability to generalize our findings to cohorts or institutions that utilize atrial catheters.
CONCLUSIONS
Postoperative LCOS is an important source of morbidity after cardiac surgery with CPB in infants; however, there is lack of consensus for diagnostic criteria of this clinical condition. In this study, we highlight the potential importance of monitoring AVco 2 in infants with complex congenital heart disease after surgery with CPB and suggest AVco 2 may be an important bedside tool to detect or confirm the presence of LCOS. AVco 2 correlates with other well-studied CO and oxygen delivery variables, and an elevated AVco 2 appears to be associated with morbidity and mortality. Importantly, AVco 2 may identify patients at risk for important morbidity immediately upon admission to the cardiovascular ICU. Prospective validation including confirmation of ability of AVco 2 to identify LCOS in real time is warranted. Future research is needed to determine if the ability of AVco 2 to independently predict clinical outcomes is reproducible and if combination with other clinical data, such as IS, could provide an early metric for severity of illness stratification as well as a target for quality improvement and clinical research initiatives.
